Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia
Open accessAbstract
DTNBP1 (dystrobrevin binding protein 1) is a leading candidate susceptibility gene in schizophrenia and is associated with working memory capacity in normal subjects. In schizophrenia, the encoded protein dystrobrevin-binding protein 1 (dysbindin-1) is often reduced in excitatory cortical limbic synapses. We found that reduced dysbindin-1 in mice yielded deficits in auditory-evoked response adaptation, prepulse inhibition of startle, and evoked γ-activity, similar to patterns in schizophrenia. In contrast to the role of dysbindin-1 in glutamatergic transmission, γ-band abnormalities in schizophrenia are most often attributed to disrupted inhibition and reductions in parvalbumin-positive interneuron (PV cell) activity. To determine the mechanism underlying electrophysiological deficits related to reduced dysbindin-1 and the potential role of PV cells, we examined PV cell immunoreactivity and measured changes in net circuit activity using voltage-sensitive dye imaging. The dominant circuit impact of reduced dysbindin-1 was impaired inhibition, and PV cell immunoreactivity was reduced. Thus, this model provides a link between a validated candidate gene and an auditory endophenotypes. Furthermore, these data implicate reduced fast-phasic inhibition as a common underlying mechanism of schizophrenia-associated intermediate phenotypes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Preclinical animal models reproducing genetic vulnerabilities or environmental risk factors show anomalies in hippocampal and/or prefrontal parvalbumin interneurons.
“Recent studies have revealed anomalies in hippocampal and/or prefrontal PVI in many preclinical animal models aiming to reproduce genetic vulnerabilities (Carlson et al., 2011; Fazzari et al., 2010; Hikida et al., 2007; Wen et al., 2010) or environmental risk factors (Brown, 2011) such as prenatal maternal stress (Stevens et al., 2013), maternal and perinatal immune challenge (Jenkins et al., 2009”
From Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology? (2016) · cites this paper as Carlson et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Delorme, A., & Makeig, S. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2003.10.009 · Cited by 24,371 · see citing works
The mouse brain in stereotaxic coordinates
Konsman, J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 16,796 · see citing works
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859 · see citing works
Interneurons of the hippocampus
Freund, T. F., & Buzsáki, G. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1996)6:4 · Cited by 3,423 · see citing works
Parvalbumin neurons and gamma rhythms enhance cortical circuit performance
Sohal, V. S., Zhang, F., Yizhar, O., & Deisseroth, K. (2009) · Nature · doi:10.1038/nature07991 · Cited by 2,606 · see citing works
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · see citing works
Abnormal neural oscillations and synchrony in schizophrenia
Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120 · see citing works
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020 · see citing works
Pyramidal neurons: dendritic structure and synaptic integration
Spruston, N. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2286 · Cited by 1,688 · see citing works
Frequency of gamma oscillations routes flow of information in the hippocampus
Colgin, L. L., Denninger, T., Fyhn, M., Hafting, T., Bonnevie, T., Jensen, O. B., Moser, M., & Moser, E. I. (2009) · Nature · doi:10.1038/nature08573 · Cited by 1,425 · see citing works
Mechanisms of Gamma Oscillations in the Hippocampus of the Behaving Rat
Csicsvari, J., Jamieson, B. G., Wise, K. D., & Buzsáki, G. (2003) · Neuron · doi:10.1016/s0896-6273(02)01169-8 · Cited by 990 · see citing works
Harrison, P. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1761-y · Cited by 693 · see citing works
A Highly Significant Association between a COMT Haplotype and Schizophrenia
Shifman, S., Bronstein, M., Sternfeld, M., Pisanté, A., Lev-Lehman, E., Weizman, A., Reznik, I., Spivak, B., Grisaru, N., Karp, L., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/344514 · Cited by 691 · see citing works
Analysis of gamma rhythms in the rat hippocampus in vitro and in vivo
Traub, R. D., Whittington, M. A., Colling, S. B., Buzsáki, G., & Jefferys, J. G. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021397 · Cited by 607 · see citing works
Neural synchrony indexes disordered perception and cognition in schizophrenia
Spencer, K., Nestor, P. G., Perlmutter, R., Niznikiewicz, M. A., Klump, M. C., Frumin, M., Shenton, M. E., & McCarley, R. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406074101 · Cited by 591 · see citing works
Instantaneous Modulation of Gamma Oscillation Frequency by Balancing Excitation with Inhibition
Atallah, B. V., & Scanziani, M. (2009) · Neuron · doi:10.1016/j.neuron.2009.04.027 · Cited by 588 · see citing works
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585 · see citing works
Kosaka, T., Katsumaru, H., Hama, K., Wu, J.-Y., & Heizmann, C. W. (1987) · Brain Research · doi:10.1016/0006-8993(87)90575-0 · Cited by 536 · see citing works
Feed‐forward dendritic inhibition in rat hippocampal pyramidal cells studied in vitro
Alger, B. E., & Nicoll, R. A. (1982) · The Journal of Physiology · doi:10.1113/jphysiol.1982.sp014255 · Cited by 528 · see citing works
Lodge, D. J., Behrens, M. M., & Grace, A. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5419-08.2009 · Cited by 488 · see citing works
Zhang, Z. J., & Reynolds, G. P. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00188-8 · Cited by 460 · see citing works
Talbot, K., Eidem, W. L., Tinsley, C. L., Benson, M. A., Thompson, E. W., Smith, R. J., Hahn, C.-G., Siegel, S. J., Trojanowski, J. Q., Gur, R. E., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20425 · Cited by 455 · see citing works
Self-citationRouting of spike series by dynamic circuits in the hippocampus
Pouille, F., & Scanziani, M. (2004) · Nature · doi:10.1038/nature02615 · Cited by 434 · see citing works
Li, W., Zhang, Q. H., Oiso, N., Novak, E. K., Gautam, R., O’Brien, E. P., Tinsley, C. L., Blake, D. J., Spritz, R. A., Copeland, N. G., et al. (2003) · Nature Genetics · doi:10.1038/ng1229 · Cited by 433 · see citing works
Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics
BEASLEY, C., & REYNOLDS, G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00122-3 · Cited by 426 · see citing works
Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1
Hayashi-Takagi, A., Takaki, M., Graziane, N., Seshadri, S., Murdoch, H., Dunlop, A. J., Makino, Y., Seshadri, A. J., Ishizuka, K., Srivastava, D. P., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2487 · Cited by 399 · see citing works
Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.
Numakawa, T., Yagasaki, Y., Ishimoto, T., Okada, T., Suzuki, T., Iwata, N., Ozaki, N., Taguchi, T., Tatsumi, M., Kamijima, K., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh280 · Cited by 373 · see citing works
Maccaferri, G., David, J., Roberts, B., Szucs, P., Cottingham, C. A., & Somogyi, P. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.t01-3-00091.x · Cited by 357 · see citing works
Validating γ oscillations and delayed auditory responses as translational biomarkers of autism
Gandal, M. J., Edgar, J. C., Ehrlichman, R. S., Mehta, M., Roberts, T. P. L., & Siegel, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.031 · Cited by 314 · see citing works
Self-citationHaenschel, C., Bittner, R. A., Waltz, J., Haertling, F., Wibral, M., Singer, W., Linden, D. E. J., & Rodriguez, E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1428-09.2009 · Cited by 303 · see citing works
Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons
Wen, L., Lu, Y.-S., Zhu, X.-H., Li, X.-M., Woo, R., Chen, Y., Yin, D., Lai, C., Terry, A. V., Vazdarjanova, A. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910302107 · Cited by 302 · see citing works
Drug-induced stimulation and suppression of action monitoring in healthy volunteers
de Bruijn, E. R. A., Hulstijn, W., Verkes, R. J., Ruigt, G. S. F., & Sabbe, B. G. C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1915-6 · Cited by 282 · see citing works
Gandal, M. J., Edgar, J. C., Klook, K., & Siegel, S. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.007 · Cited by 269 · see citing works
Self-citationHippocampal modulation of sensorimotor processes.
Bast, T., & Feldon, J. (2003) · Progress in neurobiology · doi:10.1016/s0301-0082(03)00112-6 · Cited by 267 · see citing works
Klausberger, T., Roberts, J. D. B., & Somogyi, P. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02513.2002 · Cited by 239 · see citing works
Singh, K. D., Barnes, G. R., & Hillebrand, A. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00249-0 · Cited by 222 · see citing works
Ketamine Modulates Theta and Gamma Oscillations
Lazarewicz, M. T., Ehrlichman, R. S., Maxwell, C. R., Gandal, M. J., Finkel, L. H., & Siegel, S. J. (2009) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2009.21305 · Cited by 209 · see citing works
Self-citationLavoie, A. M., Tingey, J., Harrison, N. L., Pritchett, D. B., & Twyman, R. E. (1997) · Biophysical Journal · doi:10.1016/s0006-3495(97)78280-8 · Cited by 205 · see citing works
Keilhoff, G., Becker, A., Grecksch, G., Wolf, G. L., & Bernstein, H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.039 · Cited by 200 · see citing works
Evoked and induced gamma-band activity of the human cortex
Pantev, C. (1995) · Brain Topography · doi:10.1007/bf01195258 · Cited by 191 · see citing works
Cunningham, M. O., Hunt, J., Middleton, S. J., LeBeau, F. E. N., Gillies, M. J., Davies, C. H., Maycox, P. R., Whittington, M. A., & Racca, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5054-05.2006 · Cited by 187 · see citing works
Bjarnadóttir, M., Misner, D., Haverfield-Gross, S., Bruun, S., Helgason, V. G., Stefánsson, H., Sigmundsson, A., Firth, D. R., Nielsen, B., Stefansdottir, R., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4314-06.2007 · Cited by 176 · see citing works
Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia
Halene, T. B., Ehrlichman, R. S., Liang, Y., Christian, E. P., Jonak, G. J., Gur, T., Blendy, J. A., Dow, H. C., Brodkin, E. S., Schneider, F. W., et al. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00504.x · Cited by 162 · see citing works
Self-citationDTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release
Chen, X.-W., Feng, Y., Hao, C., Guo, X., He, X., Zhou, Z.-Y., Guo, N., Huang, H.-P., Xiong, W., Zheng, H., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711021 · Cited by 161 · see citing works
Ketamine Produces Lasting Disruptions in Encoding of Sensory Stimuli
Maxwell, C. R., Ehrlichman, R. S., Liang, Y., Trief, D., Kanes, S., Karp, J. D., & Siegel, S. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.091199 · Cited by 160 · see citing works
Self-citationRojas, D. C., Maharajh, K., Teale, P. D., & Rogers, S. J. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-66 · Cited by 158 · see citing works
Ang, C. W., Carlson, G. C., & Coulter, D. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2354-06.2006 · Cited by 150 · see citing works
Self-citationDysbindin-1 is a synaptic and microtubular protein that binds brain snapin
Talbot, K., Cho, D.-S., Ong, W., Benson, M. A., Han, L.-Y., Kazi, H., Kamins, J., Hahn, C.-G., Blake, D. J., & Arnold, S. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl246 · Cited by 148 · see citing works
Self-citationRole of dysbindin in dopamine receptor trafficking and cortical GABA function
Ji, Y., Yang, F., Papaleo, F., Wang, H.-X., Gao, W., Weinberger, D. R., & Lu, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904289106 · Cited by 141 · see citing works
Bitanihirwe, B., Lim, M., Kelley, J., Kaneko, T., & Woo, T. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-71 · Cited by 137 · see citing works
Steady state and induced auditory gamma deficits in schizophrenia
Krishnan, G. P., Hetrick, W. P., Brenner, C. A., Shekhar, A., Steffen, A., & O’Donnell, B. F. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.03.085 · Cited by 135 · see citing works
FENG, Y., ZHOU, Z., HE, X., WANG, H., Guo, X. W., HAO, C., GUO, Y., Zhen, X., & Li, W. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.018 · Cited by 135 · see citing works
Ehrlichman, R. S., Luminais, S. N., White, S., Rudnick, N. D., Ma, N., Dow, H. C., Kreibich, A. S., Abel, T. G., Brodkin, E. S., Hahn, C.-G., et al. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.065 · Cited by 134 · see citing works
Self-citationGenetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia
Petryshen, T. L., Middleton, F. A., Tahl, A. R., Rockwell, G. N., Purcell, S., Aldinger, K. A., Kirby, A. W., Morley, C. P., McGann, L., Gentile, K. L., et al. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001739 · Cited by 131 · see citing works
Tang, J., LeGros, R. P., Louneva, N., Yeh, L., Cohen, J. W., Hahn, C.-G., Blake, D. J., Arnold, S. E., & Talbot, K. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp329 · Cited by 124 · see citing works
Self-citationPDE inhibitors in psychiatry – future options for dementia, depression and schizophrenia?
Halene, T. B., & Siegel, S. J. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.023 · Cited by 122 · see citing works
Self-citationKarlsgodt, K. H., Robleto, K., Trantham‐Davidson, H., Jairl, C., Cannon, T. D., Lavı́n, A., & Jentsch, J. D. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.012 · Cited by 119 · see citing works
Donohoe, G. J., Morris, D. W., Clarke, S., McGhee, K. A., Schwaiger, S., Nangle, J. M., Garavan, H., Robertson, I. H., Gill, M., & Corvin, A. P. (2006) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2006.06.016 · Cited by 119 · see citing works
Association Between the Neuregulin 1 Gene and Schizophrenia: A Systematic Review
Tosato, S. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi043 · Cited by 117 · see citing works
Ang, C. W., Carlson, G. C., & Coulter, D. A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2992-05.2005 · Cited by 116 · see citing works
Self-citationNeurobehavioral abnormalities in the dysbindin‐1 mutant, sandy, on a C57BL/6J genetic background
Cox, M. M., Tucker, A. M., Tang, J., Talbot, K., Richer, D. C., Yeh, L., & Arnold, S. E. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00477.x · Cited by 110 · see citing works
Self-citationZhang, Y., Behrens, M. M., & Lisman, J. E. (2008) · Journal of Neurophysiology · doi:10.1152/jn.00079.2008 · Cited by 107 · see citing works
The dystrobrevin-binding protein 1 gene: features and networks
Guo, A. Y., Sun, J., Riley, B. P., Thiselton, D. L., Kendler, K. S., & Zhao, Z. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.88 · Cited by 100 · see citing works
Dysbindin Modulates Prefrontal Cortical Glutamatergic Circuits and Working Memory Function in Mice
Jentsch, J. D., Trantham‐Davidson, H., Jairl, C., Tinsley, M. R., Cannon, T. D., & Lavı́n, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.90 · Cited by 100 · see citing works
Ford, J. M., Mathalon, D. H., Kalba, S., Marsh, L., & Pfefferbaum, A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01051-9 · Cited by 96 · see citing works
Spencer, K. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.033.2009 · Cited by 96 · see citing works
The early auditory gamma-band response is heritable and a putative endophenotype of schizophrenia
Hall, M.-H., Taylor, G., Sham, P., Schulze, K., Rijsdijk, F., Picchioni, M., Toulopoulou, T., Ettinger, U., Bramon, E., Murray, R. M., et al. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp134 · Cited by 95 · see citing works
Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression
Tang, T. T.-T., Yang, F., Chen, B.-S., Lü, Y., Ji, Y., Roche, K. W., & Lu, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910499106 · Cited by 94 · see citing works
Behavioral characterization of dysbindin-1 deficient sandy mice
Bhardwaj, S. K., Baharnoori, M., Sharif-Askari, B., Kamath, A., Williams, S., & Srivastava, L. K. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.011 · Cited by 88 · see citing works
Carlson, G. C., & Coulter, D. A. (2008) · Nature Protocols · doi:10.1038/nprot.2007.539 · Cited by 88 · see citing works
Self-citationAnokhin, A. P., Vedeniapin, A. B., Heath, A. C., Korzyukov, O. A., & Boutros, N. N. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.08.009 · Cited by 88 · see citing works
Vilella, E., Costas, J., Sanjuán, J., Guitart, M., de Diego‐Otero, Y., Carracedo, Á., Martorell, L., Valero, J., Labad, A., Frutos, R. D., et al. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.02.005 · Cited by 85 · see citing works
Cadenhead, K. S., Light, G. A., Shafer, K. M., & BRAFF, D. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.003 · Cited by 81 · see citing works
Sun, J., Jia, P., Fanous, A. H., Webb, B. T., van den Oord, E. J. C. G., Chen, X., Bukszár, J., Kendler, K. S., & Zhao, Z. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp428 · Cited by 80 · see citing works
The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research
Talbot, K. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17910-4 · Cited by 73 · see citing works
Self-citationKalus, P., Senitz, D., & Beckmann, H. (1997) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(97)00020-6 · Cited by 67 · see citing works
Early Visual Processing Deficits in Dysbindin-Associated Schizophrenia
Donohoe, G. J., Morris, D. W., Sanctis, P. D., Magno, E., Montesi, J. L., Garavan, H., Robertson, I. H., Javitt, D. C., Gill, M., Corvin, A. P., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.022 · Cited by 64 · see citing works
Halene, T. B., & Siegel, S. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138586 · Cited by 58 · see citing works
Self-citationGenetic Susceptibility to Schizophrenia: Role of Dopaminergic Pathway Gene Polymorphisms
Gupta, M., Chauhan, C. R., Bhatnagar, P., Gupta, S., Grover, S., Singh, P. K., Purushottam, M., Mukherjee, O., Jain, S., Brahmachari, S. K., et al. (2009) · Pharmacogenomics · doi:10.2217/14622416.10.2.277 · Cited by 54 · see citing works
Connolly, P. M., Maxwell, C. R., Kanes, S., Abel, T. G., Liang, Y., Tokarczyk, J., Bilker, W. B., Turetsky, B. I., Gur, R. E., & Siegel, S. J. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.035 · Cited by 52 · see citing works
Self-citationRéthelyi, J., Bakker, S. C., Polgár, P., Czobor, P., Strengman, E., Pásztor, P., Kahn, R. S., & Bitter, I. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31049 · Cited by 51 · see citing works
Dysbindin-1 genotype effects on emotional working memory
Wolf, C., Jackson, M. C., Kissling, C., Thome, J., & Linden, D. E. J. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.129 · Cited by 43 · see citing works
Nagai, T., Kitahara, Y., Shiraki, A., Hikita, T., Taya, S., Kaibuchi, K., & Yamada, K. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.12.071 · Cited by 38 · see citing works
Chen, J., Tsang, S., Zhao, C., Pun, F. W., Yu, Z., Mei, L., Lo, W.-S., Fang, S., Liu, H., Stöber, G., et al. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371415 · Cited by 38 · see citing works
Bodarky, C. L., Halene, T. B., Ehrlichman, R. S., Banerjee, A., Ray, R., Hahn, C.-G., Jonak, G. J., & Siegel, S. J. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.150938 · Cited by 16 · see citing works
Self-citation
Flagged first, then by citations
1 of the 86 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
McCutcheon, R. A., Krystal, J. H., & Howes, O. D. (2020) · World Psychiatry · doi:10.1002/wps.20693 · Cited by 612 · see citing works
Ferguson, B. R., & Gao, W.-J. (2018) · Frontiers in Neural Circuits · doi:10.3389/fncir.2018.00037 · Cited by 594 · see citing works
Uhlhaas, P. J., & Singer, W. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.004 · Cited by 512 · see citing works
Steullet, P., Cabungcal, J.-H., Coyle, J., Didriksen, M., Gill, K., Grace, A. A., Hensch, T. K., LaMantia, A.-S., Lindemann, L., Maynard, T. M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.47 · Cited by 360 · see citing works
The NMDA Receptor and Schizophrenia
Balu, D. T. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.006 · Cited by 285 · see citing works
Steullet, P., Cabungcal, J. H., Monin, A., Dwir, D., O'Donnell, P., Cuenod, M., & Do, K. Q. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2014.06.021 · Cited by 262 · see citing works
Perez, V. B., Woods, S. W., Roach, B. J., Ford, J. M., McGlashan, T. H., Srihari, V. H., & Mathalon, D. H. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.038 · Cited by 246 · see citing works
Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders
Selten, M. M., van Bokhoven, H., & Kasri, N. N. (2018) · F1000Research · doi:10.12688/f1000research.12155.1 · Cited by 208 · see citing works
The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond
Balu, D. T., & Coyle, J. T. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.004 · Cited by 208 · see citing works
High-frequency oscillations and the neurobiology of schizophrenia
Uhlhaas, P. J., & Singer, W. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.3/puhlhaas · Cited by 196 · see citing works
Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
Pratt, J. A., Winchester, C. L., Dawson, N., & MORRIS, B. J. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3649 · Cited by 189 · see citing works
Do, K. Q., Cuenod, M., & Hensch, T. K. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv065 · Cited by 158 · see citing works
Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?
Gandal, M. J., Anderson, R. L., Billingslea, E. N., Carlson, G. C., Roberts, T. P. L., & Siegel, S. J. (2012) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2012.00816.x · Cited by 120 · see citing works
Self-citationModeling psychiatric disorders at the cellular and network levels
Brennand, K. J., Simone, A., Tran, N., & Gage, F. H. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.20 · Cited by 119 · see citing works
Billingslea, E. N., Tatard-Leitman, V. M., Anguiano, J., Jutzeler, C. R., Suh, J., Saunders, J. A., Morita, S., Featherstone, R. E., Ortinski, P. I., Gandal, M. J., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.7 · Cited by 115 · see citing works
Self-citationLosing your inhibition: Linking cortical GABAergic interneurons to schizophrenia
Inan, M., Petros, T. J., & Anderson, S. A. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.013 · Cited by 100 · see citing works
Kocsis, B., Brown, R. E., McCarley, R. W., & Hajós, M. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12081 · Cited by 93 · see citing works
Lohani, S., Martig, A. K., Deisseroth, K. A., Witten, I. B., & Moghaddam, B. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.012 · Cited by 88 · see citing works
NMDA antagonists recreate signal-to-noise ratio and timing perturbations present in schizophrenia
Saunders, J. A., Gandal, M. J., & Siegel, S. J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.049 · Cited by 89 · see citing works
Self-citationJiang, Z., Cowell, R. M., & Nakazawa, K. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00116 · Cited by 89 · see citing works
Gilani, A., Chohan, M. O., Inan, M., Schobel, S., Chaudhury, N. H., Paskewitz, S., Chuhma, N., Glickstein, S. B., Merker, R. J., Xu, Q., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316488111 · Cited by 87 · see citing works
Tanaka, M., Spekker, E., Szabó, Á., Polyák, H., & Vécsei, L. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02513-5 · Cited by 84 · see citing works
Cytosolic Accumulation of L-Proline Disrupts GABA-Ergic Transmission through GAD Blockade
Crabtree, G. W., Park, A. J., Gordon, J. A., & Gogos, J. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.029 · Cited by 77 · see citing works
Brain Rhythms Connect Impaired Inhibition to Altered Cognition in Schizophrenia
Pittman-Polletta, B., Kocsis, B., Vijayan, S., Whittington, M. A., & Kopell, N. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.005 · Cited by 75 · see citing works
Uchida, T., Furukawa, T., Iwata, S., Yanagawa, Y., & Fukuda, A. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.13 · Cited by 73 · see citing works
Gandal, M. J., Nesbitt, A. M., McCurdy, R. M., & Alter, M. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041215 · Cited by 67 · see citing works
Self-citationLiao, W., Gandal, M. J., Ehrlichman, R. S., Siegel, S. J., & Carlson, G. C. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.048 · Cited by 57 · see citing works
Self-citationPort, R. G., Gajewski, C. R., Krizman, E. N., Dow, H. C., Hirano, S., Brodkin, E. S., Carlson, G. C., Robinson, M. B., Roberts, T. P. L., & Siegel, S. J. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.013 · Cited by 54 · see citing works
Self-citationHigh-frequency neural oscillations and visual processing deficits in schizophrenia
Tan, H. M., Lana, L., & Uhlhaas, P. J. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00621 · Cited by 52 · see citing works
Oscillotherapeutics – Time-targeted interventions in epilepsy and beyond
Takeuchi, Y., & Berényi, A. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.01.002 · Cited by 51 · see citing works
Mullin, A. P., Sadanandappa, M. K., Ma, W., Dickman, D. K., VijayRaghavan, K., Ramaswami, M., Sanyal, S., & Faúndez, V. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3542-14.2015 · Cited by 49 · see citing works
Implicit Timing as the Missing Link between Neurobiological and Self Disorders in Schizophrenia?
Giersch, A., Lalanne, L., & Isope, P. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00303 · Cited by 49 · see citing works
Wang, X., Pinto-Duarte, A., Sejnowski, T. J., & Behrens, M. M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4907 · Cited by 46 · see citing works
Cellular and circuit models of increased resting-state network gamma activity in schizophrenia
White, R. S., & Siegel, S. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.011 · Cited by 42 · see citing works
Self-citationGardner, R. J., Kersanté, F., Jones, M. W., & Bartsch, U. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12533 · Cited by 40 · see citing works
Santos‐Silva, T., Fabris, D. D. S., de Oliveira, C. L., Guimarães, F. S., & Gomes, F. V. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad123 · Cited by 42 · see citing works
Port, R. G., Gandal, M. J., Roberts, T. P. L., Siegel, S. J., & Carlson, G. C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00414 · Cited by 38 · see citing works
Self-citationElectrophysiological Endophenotypes in Rodent Models of Schizophrenia and Psychosis
Rosen, A. M., Spellman, T., & Gordon, J. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.021 · Cited by 37 · see citing works
Yuan, Q., Yang, F., Xiao, Y., Tan, S., Husain, N., Ren, M., Hu, Z.-H., Martinowich, K., Ng, J. S., Kim, P., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.019 · Cited by 38 · see citing works
Abnormal cortical neural synchrony during working memory in schizophrenia
Kang, S. S., MacDonald, A. W., Chafee, M. V., Im, C., Bernat, E. M., Davenport, N. D., & Sponheim, S. R. (2017) · Clinical Neurophysiology · doi:10.1016/j.clinph.2017.10.024 · Cited by 35 · see citing works
Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning
Glen, W. B., Horowitz, B. L., Carlson, G. C., Cannon, T. D., Talbot, K., Jentsch, J. D., & Lavı́n, A. (2013) · Hippocampus · doi:10.1002/hipo.22215 · Cited by 33 · see citing works
Self-citationLarimore, J. L., Zlatic, S. A., Gokhale, A., Tornieri, K., Singleton, K. S., Mullin, A. P., Tang, J. X., Talbot, K., & Faúndez, V. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.553750 · Cited by 34 · see citing works
Self-citationThe Adenosine Neuromodulation System in Schizophrenia
Rial, D., Lara, D. R., & Cunha, R. A. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00016-7 · Cited by 32 · see citing works
Shahriari, Y., Krusienski, D. J., Dadi, Y. S., Seo, M., Shin, H., & Choi, J. H. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1112036 · Cited by 32 · see citing works
Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice
Saggu, S., Cannon, T. D., Jentsch, J. D., & Lavı́n, A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.037 · Cited by 32 · see citing works
Synapse-specific contributions in the cortical pathology of schizophrenia
Seshadri, S., Zeledón, M., & Sawa, A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.009 · Cited by 29 · see citing works
Celada, P., Lladó-Pelfort, L., Santana, N., Kargieman, L., Troyano‐Rodriguez, E., Riga, M. S., & Artigas, F. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000643 · Cited by 31 · see citing works
Toriumi, K., Oki, M., Muto, E., Tanaka, J., Mouri, A., Mamiya, T., Kim, H., & Nabeshima, T. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4288-8 · Cited by 31 · see citing works
Hartwig, C. L., Monis, W. J., Chen, X., Dickman, D. K., Pazour, G. J., & Faúndez, V. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22542 · Cited by 29 · see citing works
Histone deacetylase-3: Friend and foe of the brain
D’Mello, S. R. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220928278 · Cited by 26 · see citing works
Dynamical changes in neurological diseases and anesthesia
McCarthy, M. M., Ching, S., Whittington, M. A., & Kopell, N. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.02.009 · Cited by 26 · see citing works
Chen, Y., Bang, S., McMullen, M. F., Kazi, H., Talbot, K., Ho, M.-X., Carlson, G. C., Arnold, S. E., Ong, W.-Y., & Kim, S. F. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9773-x · Cited by 25 · see citing works
Self-citationChamberlin, L. A., Yang, S.-S., McEachern, E., Lucas, J. T. M., McLeod, O. W., Rolland, C. A., Mack, N. R., Ferguson, B. R., & Gao, W. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01576-6 · Cited by 25 · see citing works
Larimore, J. L., Zlatic, S. A., Arnold, M., Singleton, K. S., Cross, R., Rudolph, H., Bruegge, M. V., Sweetman, A., Garza, C., Whisnant, E., et al. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00028 · Cited by 21 · see citing works
Schizophrenia: from neurophysiological abnormalities to clinical symptoms
Castelnovo, A., Ferrarelli, F., & D’Agostino, A. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.00478 · Cited by 21 · see citing works
Carlson, G. C., Lin, R., Chen, Y., Brookshire, B. R., White, R. S., Lucki, I., Siegel, S. J., & Kim, S. F. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.063 · Cited by 20 · see citing works
Self-citationWang, T., Sinha, A. S., Akita, T., Yanagawa, Y., & Fukuda, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00284 · Cited by 18 · see citing works
Structural and functional neuroimaging phenotypes in dysbindin mutant mice
Lutkenhoff, E. S., Karlsgodt, K. H., Gutman, B. A., Stein, J. L., Thompson, P. M., Cannon, T. D., & Jentsch, J. D. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.05.008 · Cited by 19 · see citing works
Malt, E. A., Juhasz, K., Malt, U. F., & Naumann, T. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00059 · Cited by 19 · see citing works
Santos‐Silva, T., Lopes, C. F. B., Ülgen, D. H., Guimarães, D. A., Guimarães, F. S., Alberici, L. C., Sandi, C., & Gomes, F. V. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae033 · Cited by 19 · see citing works
Sinclair, D., Cesare, J., McMullen, M. F., Carlson, G. C., Hahn, C.-G., & Borgmann‐Winter, K. E. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9148-7 · Cited by 18 · see citing works
Self-citationBDNF rescues prefrontal dysfunction elicited by pyramidal neuron-specific DTNBP1 deletion in vivo
Zhang, W., Daly, K., Liang, B., Zhang, L., Li, X., Li, Y., & Lin, D.-T. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw029 · Cited by 17 · see citing works
Ward, K. R., Featherstone, R. E., Naschek, M. J., Melnychenko, O., Banerjee, A., Yi, J., Gifford, R. L., Borgmann‐Winter, K. E., Salter, M. W., Hahn, C.-G., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.017 · Cited by 18 · see citing works
Self-citationIncreased dysbindin-1B isoform expression in schizophrenia and its propensity in aggresome formation
Xu, Y., Sun, Y., Ye, H., Zhu, L., Liu, J., Wu, X., Wang, L., He, T., Shen, Y., Wu, J. Y., et al. (2015) · Cell Discovery · doi:10.1038/celldisc.2015.32 · Cited by 17 · see citing works
Petit, E., Michalak, Z., Cox, R. F., O’Tuathaigh, C. M. P., Clarke, N. E., Tighe, O., Talbot, K., Blake, D. J., Joel, J., Shaw, A., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.282 · Cited by 17 · see citing works
Self-citationPort, R. G., Berman, J., Liu, S., Featherstone, R. E., Roberts, T. P. L., & Siegel, S. J. (2018) · Brain Connectivity · doi:10.1089/brain.2018.0639 · Cited by 17 · see citing works
Self-citationWaddington, J. L., Zhen, X., & O’Tuathaigh, C. M. P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01638 · Cited by 16 · see citing works
Role of murine models in psychiatric illness drug discovery: a dimensional view
Hoffman, K. L. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.797959 · Cited by 14 · see citing works
Duan, J. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1488-2 · Cited by 14 · see citing works
Dysbindin-1 regulates mitochondrial fission and gamma oscillations
Zhao, J. W., Zhu, H., Duan, K., Petralia, R. S., Wang, Y., Gu, Q., Panja, D., & Li, Z. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01038-9 · Cited by 14 · see citing works
Huang, C. C., Muszynski, K., Bolshakov, V. Y., & Balu, D. T. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0465-y · Cited by 13 · see citing works
Birjandian, Z., Narla, C., & Poulter, M. O. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00183 · Cited by 12 · see citing works
Sensory encoding in Neuregulin 1 mutants
Barz, C. S., Bessaïh, T., Abel, T. G., Feldmeyer, D., & Contreras, D. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0955-x · Cited by 12 · see citing works
Al‐Shammari, A. R., Bhardwaj, S. K., Musaelyan, K., Srivastava, L. K., & Szele, F. G. (2018) · Schizophrenia · doi:10.1038/s41537-018-0057-5 · Cited by 12 · see citing works
Ceftriaxone reverses ketamine-induced lasting EEG and astrocyte alterations in juvenile mice
Dodman, K. G., Featherstone, R. E., Bang, J., Liang, Y., & Siegel, S. J. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.07.1198 · Cited by 12 · see citing works
Self-citationWang, W., Deng, D., Jenkins, K., Zinsmaier, A. K., Zhou, Q., & Bao, S. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.12.006 · Cited by 10 · see citing works
Miller, G. A., & Rockstroh, B. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00010-0 · Cited by 11 · see citing works
Muhtaseb, A. W., & Duan, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.04.003 · Cited by 11 · see citing works
Loss of dysbindin-1 affects GABAergic transmission in the PFC
Trantham‐Davidson, H., & Lavı́n, A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05285-1 · Cited by 10 · see citing works
Cloutier, M., Srivastava, L. K., & Cermakian, N. (2022) · Journal of Biological Rhythms · doi:10.1177/07487304221125363 · Cited by 9 · see citing works
Dysbindin‐1 modifies signaling and cellular localization of recombinant, human D3and D2receptors
Schmieg, N., Rocchi, C., Romeo, S., Maggio, R., Millan, M. J., & la Cour, C. M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13501 · Cited by 8 · see citing works
Mutant Mouse Models in Evaluating Novel Approaches to Antipsychotic Treatment
O’Tuathaigh, C. M. P., Desbonnet, L., & Waddington, J. L. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_5 · Cited by 8 · see citing works
How many genes are involved in schizophrenia? A simple simulation
Paek, M. J., & Kang, U. G. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.015 · Cited by 7 · see citing works
Bhardwaj, S. K., Cui, Q., Moquin, L., Gratton, A. P., Bruno Giros, A., & Srivastava, L. K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108440 · Cited by 6 · see citing works
Mouse model of OPRM1 (A118G) polymorphism has altered hippocampal function
Mague, S. D., Port, R. G., McMullen, M. E., Carlson, G. C., & Turner, J. R. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.032 · Cited by 6 · see citing works
Self-citationDysbindin deficiency Alters Cardiac BLOC-1 Complex and Myozap Levels in Mice
Borlepawar, A., Schmiedel, N., Eden, M., Christen, L., Rosskopf, A., Frank, D., Lüllmann‐Rauch, R., Frey, N., & Rangrez, A. Y. (2020) · Cells · doi:10.3390/cells9112390 · Cited by 5 · see citing works
Rumschlag, J. A., Lovelace, J. W., Kokash, J., Hussain, A., & Razak, K. A. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.07.014 · Cited by 5 · see citing works
Dysbindin-1, a schizophrenia-related protein, interacts with HDAC3
Soma, M., Wang, M., Suo, S., & Ishiura, S. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.08.046 · Cited by 5 · see citing works
Trombka, D., & Meiron, O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157514 · Cited by 3 · see citing works
Decoding Advances in Psychiatric Genetics
Heckenast, J. R., Wilkinson, L. S., & Jones, M. W. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.09.001 · Cited by 2 · see citing works
Cellular and Circuit Models of Increased Resting State Network Gamma Activity in Schizophrenia
White, R. S., & Siegel, S. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801829-3.00022-7 · Cited by 2 · see citing works
Self-citationBlocking Src-PSD-95 interaction rescues glutamatergic signaling dysregulation in schizophreniaPreprint
Featherstone, R. E., Li, H., Sengar, A. S., Borgmann‐Winter, K. E., Melnychenko, O., Crown, L. M., Gifford, R. L., Amirfathi, F., Banerjee, A., Parekh, K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.08.584132 · Cited by 2 · see citing works
Self-citationProtein-protein interaction–interfering peptide rescues dysregulated NMDA receptor signaling
Featherstone, R. E., Li, H., Sengar, A. S., Borgmann‐Winter, K. E., Melnychenko, O., Crown, L. M., Gifford, R. L., Amirfathi, F., Banerjee, A., Tran, A., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.189634 · Cited by 2 · see citing works
Self-citationAbazyan, S., & Pletnikov, M. V. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.017 · Cited by 1 · see citing works
Santos‐Silva, T., Lopes, C. F. B., Ülgen, D. H., Guimarães, D. A., Guimarães, F. S., Alberici, L. C., Sandi, C., & Gomes, F. V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.28.568850 · Cited by 1 · see citing works
Nmda Receptor Dysfunction And Development Of Translational Biomarkers For Autism And Schizophrenia
Saunders, J. A. (2012) · ScholarlyCommons (University of Pennsylvania)
Social dysfunction and mental retardation
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.010
Balu, D. T., & GOFF, D. C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.005
- Authors
- Carlson, G. C., Talbot, K., Halene, T. B., Gandal, M. J., Kazi, H. A., Schlosser, L., Phung, Q. H., Gur, R. E., Arnold, S. E., & Siegel, S. J.
- Affiliations
- University of Pennsylvania (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-10-03
- Volume
- 108
- Issue
- 43
- Pages
- E962-70
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3203764
- OpenAlex
- W2117959142
- Cited by
- 103
- References
- 86
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 6 · 2019: 4 · 2018: 5 · 2017: 5 · 2016: 13 · 2015: 13 · 2014: 14 · 2013: 12 · 2012: 15
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (IRTG1328)
- National Institutes of Health (5r01da023210-05, 5p50mh064045-10, MH64045)
- National Institute of Mental Health (P50 MH-064045, MH072880, R01MH072880, P50 MH 64045)
- National Institute on Drug Abuse (R01-DA023210, 5R01-DA02321002)
- National Cancer Institute (P50CA084718)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- dysbindin-1, DTNBP1, schizophrenia, parvalbumin interneurons, prepulse inhibition, gamma oscillations, glutamatergic neurotransmission, candidate susceptibility genes, endophenotypes, voltage-sensitive dye imaging
- MeSH terms
- Dysbindin, Animals, Carrier Proteins, Electrophysiology, Evoked Potentials, Auditory, Female, Genotype, Immunohistochemistry, Limbic System, Male, Mice, Mutant Strains, Parvalbumins, Schizophrenia, Synapses, Dystrophin-Associated Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review